Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease

Journal of Psychosomatic Research

Volumn 89, Issue , 2016, Pages 107-113

  Marrie, Ruth Ann ^a   Walker, John R ^a   Graff, Lesley A ^a   Lix, Lisa M ^a,b   Bolton, James M ^a,b   Nugent, Zoann ^a   Targownik, Laura E ^a   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Administrative data; Anxiety; Depression; Inflammatory bowel disease; Population based; Validation

Indexed keywords

ADMINISTRATIVE CLAIMS (HEALTH CARE); ADULT; ANXIETY DISORDER; ARTICLE; COMPARATIVE STUDY; DEPRESSION; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MANITOBA; PERFORMANCE MEASUREMENT SYSTEM; PREVALENCE; ANXIETY; CANADA; COHORT ANALYSIS; COMORBIDITY; HEALTH SURVEY; INFLAMMATORY BOWEL DISEASES; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ADMINISTRATIVE CLAIMS, HEALTHCARE; ANXIETY; CANADA; COHORT STUDIES; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MANITOBA; POPULATION SURVEILLANCE; PREVALENCE;

EID: 84985997734     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2016.08.014     Document Type: Article

References (28)

1. [1] Kaplan, G.G., The global burden of IBD: from 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 12 (2015), 720–727.
2. [2] Bernstein, C.N., Wajda, A., Blanchard, J.F., The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129 (2005), 827–836.
3. [3] Graff, L.A., Walker, J.R., Bernstein, C.N., Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm. Bowel Dis. 15 (2009), 1105–1118.
4. [4] Walker, J.R., Ediger, J.P., Graff, L.A., et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am. J. Gastroenterol. 103 (2008), 1989–1997.
5. [5] Mittermaier, C., Dejaco, C., Waldhoer, T., et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom. Med. 66 (2004), 79–84.
6. [6] Israeli, E., Graff, L.A., Clara, I., et al. Low prevalence of disability among patients with inflammatory bowel diseases a decade after diagnosis. Clin. Gastroenterol. Hepatol. 12 (2014), 1330–1337, e1332.
7. [7] Faust, A.H., Halpern, L.F., Danoff-Burg, S., et al. Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life. Gastroenterol. Hepatol. (N. Y.) 8 (2012), 173–181.
8. [8] Mohr, D.C., Goodkin, D.E., Likosky, W., et al. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch. Neurol. 54 (1997), 531–533.
9. [9] Patten, S., Integrating data from clinical and administrative databases in pharmacoepidemiological research. Can. J. Clin. Pharmacol. 5 (1998), 92–97.
10. [10] Martens, P., Fransoo, R., McKeen, N., et al. Patterns of regional mental illness disorder diagnoses and service use in Manitoba: a population-based study. Available at mchp-appserv.cpe.umanitoba.ca/reference/mental.health.pdf, 2004.
11. [11] West, S.L., Richter, A., Melfi, C.A., et al. Assessing the Saskatchewan database for outcomes research studies of depression and its treatment. J. Clin. Epidemiol. 53 (2000), 823–831.
12. [12] Marrie, R.A., Fisk, J.D., Yu, B.N., et al. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol., 13, 2013, 16.
13. [13] Samkoff, L.M., Goodman, A.D., Symptomatic management in multiple sclerosis. Neurol. Clin. 29 (2011), 449–463.
14. [14] Longobardi, T., Walker, J., Graff, L., et al. Health service utilization in IBD: comparison of self-report and administrative data. BMC Health Serv. Res., 11, 2011, 137.
15. [15] Horton, M., Rudick, R.A., Hara-Cleaver, C., et al. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology 35 (2010), 83–90.
16. [16] Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data. Biometrics 33 (1977), 159–174.
17. [17] Docherty, M.J., Jones, R.C. III, Wallace, M.S., Managing pain in inflammatory bowel disease. Gastroenterol. Hepatol. (N. Y.) 7 (2011), 592–601.
18. [18] Kleinbaum, D., Kupper, L., Morgenstern, H., Information bias. Epidemiologic Research: Principles and Quantitative Methods, 1982, Van Nostrand Reinhold, New York, 220–241.
19. [19] Haro, J.M., Arbabzadeh-Bouchez, S., Brugha, T.S., et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys. Int. J. Methods Psychiatr. Res. 15 (2006), 167–180.
20. [20] Elixhauser, A., Steiner, C., Harris, D.R., et al. Comorbidity measures for use with administrative data. Med. Care 36 (1998), 8–27.
21. [21] Marrie, R.A., Fisk, J.D., Stadnyk, K.J., et al. Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia. Chron. Dis. Inj. Can. 34 (2014), 145–153.
22. [22] Ruscio, A.M., Brown, T.A., Chiu, W.T., et al. Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychol. Med. 38 (2008), 15–28.
23. [23] Kisely, S., Lin, E., Gilbert, C., et al. Use of administrative data for the surveillance of mood and anxiety disorders. Aust. N. Z. J. Psychiatry 43 (2009), 1118–1125.
24. [24] Wang, P.S., Angermeyer, M., Borges, G., et al. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6 (2007), 177–185.
25. [25] Alonso, J., Codony, M., Kovess, V., et al. Population level of unmet need for mental healthcare in Europe. Br. J. Psychiatry 190 (2007), 299–306.
26. [26] Mojtabai, R., Unmet need for treatment of major depression in the United States. Psychiatr. Serv. 60 (2009), 297–305.
27. [27] Kessler, R.C., Berglund, P., Demler, O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003), 3095–3105.
28. [28] Kessler, R.C., Berglund, P., Demler, O., et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62 (2005), 593–602.